Global Encephalitis Vaccines Market Size, Share, and COVID-19 Impact Analysis, By Vaccine Type (Mouse Brain-Derived Inactivated Vaccine, Cell Culture-Derived Inactivated Vaccine, Cell Culture-Derived Live Attenuated Vaccine), Indication Type (Japanese Encephalitis, Tick-Borne Encephalitis, Rabies Encephalitis), By End-User (Child and Adult), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 - 2032

Industry: Healthcare
RELEASE DATE May 2023
REPORT ID SI1901
PAGES 200
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis by Vaccine Type
      2. Market Attractiveness Analysis by Indication Type
      3. Market Attractiveness Analysis by End User
      4. Market Attractiveness Analysis by Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising prevalence of encephalitis
    3. Restraints
      1. High cost of vaccine
    4. Opportunities
      1.  The development of new vaccines
    5. Challenges
      1. Limited Access to Healthcare
  6. Global Encephalitis Vaccines Market Analysis and Projection, By Vaccine Type
    1. Segment Overview
    2. Mouse Brain-Derived Inactivated Vaccine
    3. Cell Culture-Derived Inactivated Vaccine
    4. Cell Culture-Derived Live Attenuated Vaccine
  7. Global Encephalitis Vaccines Market Analysis and Projection, By Indication Type
    1. Japanese Encephalitis
    2. Tick-Borne Encephalitis
    3. Rabies Encephalitis
    4. Others
  8. Global Encephalitis Vaccines Market Analysis and Projection, By End Users
    1. Child
    2. Adults

 

  1. Global Encephalitis Vaccines Market, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  2. Global Encephalitis Vaccines Market -Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Global Encephalitis Vaccines Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  3. Company Profiles
    1. Liaoning Cheng Bio Co
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2. Wuhan Institute of Biological Products
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Valneva
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4. Tiantan Biological Products
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.  Sanofi Pasteur  
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6. Chengdu Institute of Biological Products
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7. GlaxoSmithKline plc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Lanzhou Institute of Biological Products
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9. Zhejiang Tianyuan Bio-Pharmaceutical
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Encephalitis Vaccines Market, By Vaccine Type, 2022-2032(USD Billion)
  2. Global Mouse Brain-Derived Inactivated Vaccine, Encephalitis Vaccines Market, By Region, 2022-2032(USD Billion)
  3. Global Cell Culture-Derived Inactivated Vaccine, Encephalitis Vaccines Market, By Region, 2022-2032(USD Billion)
  4. Global ell Culture-Derived Live Attenuated Vaccine, Encephalitis Vaccines Market, By Region, 2022-2032(USD Billion)
  5. Global Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  6. Global Japanese Encephalitis, Encephalitis Vaccines Market, By Region, 2022-2032(USD Billion)
  7. Global Tick-Borne Encephalitis, Encephalitis Vaccines Market, By Region, 2022-2032(USD Billion)
  8. Global Rabies Encephalitis, Encephalitis Vaccines Market, By Region, 2022-2032(USD Billion)
  9. Global Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion)
  10. Global Child, Encephalitis Vaccines Market, By Region, 2022-2032(USD Billion)
  11. Global Adults, Encephalitis Vaccines Market, By Region, 2022-2032(USD Billion)
  12. Global Encephalitis Vaccines Market, By Region, 2022-2032(USD Billion)
  13. North America Encephalitis Vaccines Market, By Vaccine Type, 2022-2032(USD Billion)
  14. North America Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  15. North America Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion)
  16. U.S. Encephalitis Vaccines Market, By Vaccine Type, 2022-2032(USD Billion)
  17. U.S. Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  18. U.S. Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion)
  19. Canada Encephalitis Vaccines Market, By Vaccine Type, 2022-2032(USD Billion)
  20. Canada Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  21. Canada Encephalitis Vaccines Market, End Users, 2022-2032(USD Billion)
  22. Mexico Encephalitis Vaccines Market, By Vaccine Type, 2022-2032(USD Billion)
  23. Mexico Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  24. Mexico Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion)
  25. Europe Encephalitis Vaccines Market, By Vaccine Type, 2022-2032(USD Billion)
  26. Europe Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  27. Europe Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion)
  28. Germany Encephalitis Vaccines Market, By Vaccine Type, 2022-2032(USD Billion)
  29. Germany Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  30. Germany Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion)
  31. France Encephalitis Vaccines Market, By Vaccine Type, 2022-2032(USD Billion)
  32. France Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  33. France Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion)
  34. U.K. Encephalitis Vaccines Market, By Vaccine Type, 2022-2032(USD Billion)
  35. U.K. Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  36. U.K. Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion)
  37. Italy Encephalitis Vaccines Market, By Vaccine Type, 2022-2032(USD Billion)
  38. Italy Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  39. Italy Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion)
  40. Spain Encephalitis Vaccines Market, By Vaccine Type, 2022-2032(USD Billion)
  41. Spain Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  42. Spain Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion)
  43. Asia Pacific Encephalitis Vaccines Market, By Vaccine Type, 2022-2032(USD Billion)
  44. Asia Pacific Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  45. Asia Pacific Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion)
  46. Japan Encephalitis Vaccines Market, By Vaccine Type, 2022-2032(USD Billion)
  47. Japan Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  48. Japan Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion)
  49. China Encephalitis Vaccines Market, By Vaccine Type, 2022-2032(USD Billion)
  50. China Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  51. China Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion)
  52. India Encephalitis Vaccines Market, By Vaccine Type, 2022-2032(USD Billion)
  53. India Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  54. India Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion)
  55. South America Encephalitis Vaccines Market, Vaccine Type, 2022-2032(USD Billion)
  56. South America Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  57. South America Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion)
  58. Brazil Encephalitis Vaccines Market, Vaccine Type, 2022-2032(USD Billion)
  59. Brazil Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  60. Brazil Encephalitis Vaccines Market, By Distribution Channel, 2022-2032(USD Billion)
  61. The Middle East and Africa Encephalitis Vaccines Market, Vaccine Type, 2022-2032(USD   Billion)
  62. The Middle East and Africa Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  63. The Middle East and Africa Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion) 
  64. UAE Encephalitis Vaccines Market, Vaccine Type, 2022-2032(USD Billion)
  65. UAE Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion) 
  66. UAE Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion) 
  67. South Africa Encephalitis Vaccines Market, Vaccine Type, 2022-2032(USD Billion)
  68. South Africa Encephalitis Vaccines Market, By Indication Type, 2022-2032(USD Billion)
  69. South Africa Encephalitis Vaccines Market, By End Users, 2022-2032(USD Billion)

List of Figures 

  1. Global Encephalitis Vaccines Market Segmentation
  2. Encephalitis Vaccines Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Encephalitis Vaccines Market
  9. Top Winning Strategies, 2022-2032
  10. Top Winning Strategies, By Development, 2022-2032(%)
  11. Top Winning Strategies, By Company, 2022-2032
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers:  Encephalitis Vaccines Market
  20. Encephalitis Vaccines Market Segmentation, By Vaccine Type
  21. Encephalitis Vaccines Market, For Mouse Brain-Derived Inactivated Vaccine, By Region, 2022-2032 ($ Billion)
  22. Encephalitis Vaccines Market, For Cell Culture-Derived Inactivated Vaccine, By Region, 2022-2032 ($ Billion)
  23. Encephalitis Vaccines Market, For Cell Culture-Derived Live Attenuated Vaccine, By Region, 2022-2032 ($ Billion)
  24. Encephalitis Vaccines Market Segmentation, By Indication Type
  25. Encephalitis Vaccines Market, For Japanese Encephalitis, By Region, 2022-2032 ($ Billion)
  26. Encephalitis Vaccines Market, For Tick-Borne Encephalitis, By Region, 2022-2032 ($ Billion)
  27. Encephalitis Vaccines Market, For Rabies Encephalitis, By Region, 2022-2032 ($ Billion)
  28. Encephalitis Vaccines Market Segmentation, By End Users
  29. Encephalitis Vaccines Market, For Child, By Region, 2022-2032 ($ Billion)
  30. Encephalitis Vaccines Market, For Adults, By Region, 2022-2032 ($ Billion)
  31. Encephalitis Vaccines Market, For Others, By Region, 2022-2032 ($ Billion)
  32. Liaoning Cheng Bio Co: Net Sales, 2022-2032 ($ Billion)
  33. Liaoning Cheng Bio Co: Revenue Share, By Segment, 2022 (%)
  34. Liaoning Cheng Bio Co: Revenue Share, By Region, 2022 (%)
  35. Wuhan Institute of Biological Products: Net Sales, 2022-2032 ($ Billion)
  36. Wuhan Institute of Biological Products: Revenue Share, By Segment, 2022 (%)
  37. Wuhan Institute of Biological Products: Revenue Share, By Region, 2022 (%)
  38. Valneva: Net Sales, 2022-2032 ($ Billion)
  39. Valneva: Revenue Share, By Segment, 2022 (%)
  40. Valneva: Revenue Share, By Region, 2022 (%)
  41. Tiantan Biological Products: Net Sales, 2022-2032 ($ Billion)
  42. Tiantan Biological Products: Revenue Share, By Segment, 2022 (%)
  43. Tiantan Biological Products: Revenue Share, By Region, 2022 (%)
  44. Sanofi Pasteur: Net Sales, 2022-2032 ($ Billion)
  45. Sanofi Pasteur: Revenue Share, By Segment, 2022 (%)
  46. Sanofi Pasteur: Revenue Share, By Region, 2022 (%)
  47. Chengdu Institute of Biological Products: Net Sales, 2022-2032 ($ Billion)
  48. Chengdu Institute of Biological Products: Revenue Share, By Segment, 2022 (%)
  49. Chengdu Institute of Biological Products: Revenue Share, By Region, 2022 (%)
  50. GlaxoSmithKline plc: Net Sales, 2022-2032 ($ Billion)
  51. GlaxoSmithKline plc: Revenue Share, By Segment, 2022 (%)
  52. GlaxoSmithKline plc: Revenue Share, By Region, 2022 (%)
  53. Lanzhou Institute of Biological Products: Net Sales, 2022-2032 ($ Billion)
  54. Lanzhou Institute of Biological Products: Revenue Share, By Segment, 2022 (%)
  55. Lanzhou Institute of Biological Products: Revenue Share, By Region, 2022 (%)
  56. Zhejiang Tianyuan Bio-Pharmaceutical: Net Sales, 2022-2032 ($ Billion)
  57. Zhejiang Tianyuan Bio-Pharmaceutical: Revenue Share, By Segment, 2022 (%)
  58. Zhejiang Tianyuan Bio-Pharmaceutical: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2022
Tables & Figures:110
Pages:200
Countries covered:17
Companies covered::20
Forecast CAGR:8.1%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies